Abstract |
Activation of the apoptosis program by an increased production of beta-amyloid peptides (Abeta) has been implicated in the neuronal cell death of Alzheimer's disease (AD). Bcl-2 is a well-demonstrated anti-apoptotic protein, however, the mechanisms of anti-apoptotic action of Bcl-2 in Abeta-induced neuronal cell death are not fully understood. In the present study, we therefore have investigated the possibility that overexpression of Bcl-2 may prevent Abeta-induced cell death through inhibition of pro-apoptotic activation of p38 MAP kinase and the transcription factor NF-kappaB in nerve growth factor ( NGF)-induced differentiated PC12 cells. Treatment of Abeta into differentiated PC12 cells transfected with plasmid alone resulted in increase of cell death determined by measurement of cytotoxicity and apoptosis in a dose dependent manner. Consistent with the increase of cell death, treatment of Abeta resulted in increase of p38 MAP kinase and NF-kappaB activation. However, overexpression of Bcl-2 reduced Abeta-induced apoptosis, and suppressed the activation of p38 MAP kinase and NF-kappaB. In addition, a p38 MAP kinase specific inhibitor SB 203580 attenuated Abeta-induced apoptosis. This inhibitory effect was correlated well with the inhibition of p38 MAP kniase and NF-kappaB activation. Moreover, inhibition of NF-kappaB activation by sodium salicylates reduced Abeta-induced apoptosis and activation of p38 MAP kinase, and up regulated Bcl-2 expression. These results suggest that Bcl-2 overexpression protects against Abeta-induced cell death of differentiated PC12, and its protective effect may be related to the reduction of Abeta-induced activation of p38 MAP kinase and NF-kappaB.
|
Authors | Youn Sook Song, Hye Ji Park, Soo Yeon Kim, Seung Ho Lee, Hwan Soo Yoo, Hee Soon Lee, Myung Koo Lee, Ki Wan Oh, Sun-Kyung Kang, Seoung Eun Lee, Jin Tae Hong |
Journal | Neuroscience research
(Neurosci Res)
Vol. 49
Issue 1
Pg. 69-80
(May 2004)
ISSN: 0168-0102 [Print] Ireland |
PMID | 15099705
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Peptides
- Enzyme Inhibitors
- Indoles
- NF-kappa B
- Protective Agents
- Proto-Oncogene Proteins c-bcl-2
- DAPI
- Nerve Growth Factor
- JNK Mitogen-Activated Protein Kinases
- Mitogen-Activated Protein Kinases
- p38 Mitogen-Activated Protein Kinases
- MAP Kinase Kinase 4
- Mitogen-Activated Protein Kinase Kinases
|
Topics |
- Amyloid beta-Peptides
(toxicity)
- Animals
- Cell Death
(drug effects)
- Cell Differentiation
(drug effects)
- Cell Survival
(drug effects)
- Dose-Response Relationship, Drug
- Drug Interactions
- Electrophoretic Mobility Shift Assay
(methods)
- Enzyme Activation
- Enzyme Inhibitors
(pharmacology)
- Flow Cytometry
(methods)
- Gene Expression Regulation
(drug effects)
- Indoles
- JNK Mitogen-Activated Protein Kinases
- MAP Kinase Kinase 4
- Mitogen-Activated Protein Kinase Kinases
(metabolism)
- Mitogen-Activated Protein Kinases
(metabolism)
- Models, Biological
- NF-kappa B
(metabolism)
- Nerve Growth Factor
(pharmacology)
- PC12 Cells
- Protective Agents
(pharmacology)
- Proto-Oncogene Proteins c-bcl-2
(physiology)
- Rats
- Transfection
- p38 Mitogen-Activated Protein Kinases
|